Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00663819 · ClinicalTrials.gov registry record · NA

Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses

A NA study, sponsored by W.L.Gore & Associates.

Terminated
Registry status
NA
Development phase
258
Enrollment target

NCT00663819 is a NA study that was terminated before completion, run by W.L.Gore & Associates. The registered enrollment target is 258 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00663819, a NA study, was terminated before completion, sponsored by W.L.Gore & Associates.

TERMINATED
Registry status
NA
Development phase
258 participants
Enrollment target

Study Summary

The primary purpose of this prospective, randomized multicenter center study is to evaluate and compare the outcomes of colorectal, coloanal and ileoanal anastomoses reinforced with a bioabsorbable staple line reinforcement material compared with standard non-reinforced colorectal, coloanal and ileoanal techniques with respect to the incidence of postoperative anastomotic leakage, anastomotic stricture and time to ileostomy closure, if applicable.

Interventions

  • DEVICE GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement
  • PROCEDURE Staple line without reinforcement

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2008-04
Est. Completion 2012-10
Phase NA

Sponsor

W.L.Gore & Associates

53 total trials

What the Registry Record Tells You About NCT00663819

The ClinicalTrials.gov registry entry for NCT00663819 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement is the first listed.

NCT00663819 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00663819 about?

NCT00663819 is a clinical study titled "Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses". The primary purpose of this prospective, randomized multicenter center study is to evaluate and compare the outcomes of colorectal, coloanal and ileoanal anastomoses reinforced with a bioabsorbable staple line reinforcement material compared with standard non-reinforced colorectal, coloanal and ileo...

What is the current status of trial NCT00663819?

This trial is currently terminated. It is a NA study. The enrollment target is 258 participants. The study started on 2008-04. Estimated completion is 2012-10.

What interventions are being tested in trial NCT00663819?

The interventions under investigation include: GORE SEAMGUARD® Bioabsorbable Staple Line Reinforcement (DEVICE), Staple line without reinforcement (PROCEDURE).

Who is sponsoring clinical trial NCT00663819?

This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.